Dose Intense Mopp for Patient with Poor Prognosis Hodgkins Disease

Gause, B L.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Intramural Research (Z01)
• Project #: 1Z01SC009337-08
• Application #: 6163346
• Study Section: Special Emphasis Panel (M)
• Support Year: 8
• Fiscal Year: 1997

Institution

• Name: National Cancer Institute Division of Clinical Sciences
• Country: United States